Artemis Medicare

ARTEMISMED03 May 2024

Healthcare

₹

-0.85 (-0.46%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Artemis Medicare

Artemis Medicare

Healthcare

ARTEMISMED03 May 2024

₹

-0.85 (-0.46%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
05-Aug-2021	S	We wish to inform you that the Board of Directors at its meeting held on 5th August, 2021, inter alia, considered and approved the following: The Sub-Division/ Split of Equity Shares of the Company. Intimation of Record Date in respect of Sub-Division of Equity Shares (As Per BSE Announcement Dated on 11.09.2021) Trading Members of the Exchange are hereby informed that ARTEMIS MEDICARE SERVICES LTD. has fixed the Record Date for the purpose of sub division of equity shares of the company : DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE ARTEMIS MEDICARE SERVICES LTD. (542919) RECORD DATE 24.09.2021 PURPOSE Sub Division of existing equity shares from every One equity share of Rs. 10/- each into Ten equity shares of Rs. 1/- each. SUB-DIVIDED PAID-UP VALUE Rs.1/- SUB-DIVIDED PAID-UP VALUE W.E.F. 23/09/2021 DR-121/2021-2022 Note:- i. ISIN No. INE025R01013 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 23/09/2021. ii. The new ISIN Number for Rs.1/- paid up will be informed to the market by a separate notice. (As Per BSE Notice Dated on 15.09.2021) In Continuation of Notice No. 20210915-58 dated September 15, 2021, Trading Members of the Exchange are hereby informed that the New ISIN number for the equity shares of the company will be as under: - Company Name & Scrip Code ARTEMIS MEDICARE SERVICES LTD. (542919) New ISIN No. INE025R01021 Remarks Sub-division of equity shares from Rs.10/- to Rs.1/- The new ISIN number given above, for Equity Shares of Rs.1/- each of the company shall be effective for trades done on and from the Ex-Date i.e. 23-09-2021 (DR-121/2021-2022) (As Per BSE Notice Dated on 20.09.2021)	24-Sep-2021
05-May-2023	D	Pursuant to Reg 30 of SEBI Listing Regulations, we wish to inform you that Board of Directors at its meeting held today i.e. 5.5.2023, inter alia, considered and approved following: Recommended the Final dividend of Re. 0.45 per Equity Share of face value of Re. 1 each (i.e. 45%) for FY23, subject to the approval of shareholders at ensuing AGM, which shall be paid/dispatched on or before 30 days from conclusion of AGM.	14-Jul-2023
05-Apr-2024	BC	Outcome of the Board Meeting-April 5, 2024	03-May-2024
05-Apr-2024	BC	Outcome of the Board Meeting-April 5, 2024 EGM of the Company scheduled to be held on Friday, May 3, 2024 (As Per BSE Announcement Dated on: 10/04/2024)	03-May-2024
16-Apr-2024	BC	Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Thursd	18-Apr-2024
02-Apr-2024	BC	Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/04/2024 inter alia to consider and approve the proposal for raising of funds	05-Apr-2024
29-Jan-2024	BC	Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2024 inter alia to consider and approve In pursuance of Regulation 29 and	05-Feb-2024

No Rights has been declared by ARTEMISMED

Book Closure

Record Date	Split Date	Purpose
03-May-2024	-	Outcome of the Board Meeting-April 5, 2024
03-May-2024	-	Outcome of the Board Meeting-April 5, 2024 EGM of the Company scheduled to be held on Friday, May 3, 2024 (As Per BSE Announcement Dated on: 10/04/2024)
18-Apr-2024	-	Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Thursd
05-Apr-2024	-	Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/04/2024 inter alia to consider and approve the proposal for raising of funds
05-Feb-2024	-	Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2024 inter alia to consider and approve In pursuance of Regulation 29 and

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Artemis Medicare Services Ltd ₹183.20(-0.85/-0.46%)	183.20	-0.85	2,519.94	130.32	55.27	7.05
Kovai Medical Center & Hospital Ltd ₹4,010.00(-50.70/-1.25%)	4,010.00	-50.70	4,442.41	105.40	28.10	5.69
Shree Pacetronix Ltd ₹219.35(-11.50/-4.98%)	219.35	-11.50	83.09	89.22	21.24	7.33
Fortis Malar Hospitals Ltd ₹87.41(-1.78/-2.00%)	87.41	-1.78	167.16	79.96	0.00	2.93
Chennai Meenakshi Multispeciality Hospital Ltd ₹36.47(+0.96/2.70%)	36.47	+0.96	26.53	70.48	98.64	148.77
Apollo Hospitals Enterprise Ltd ₹6,025.00(+69.00/1.16%)	6,025.00	+69.00	85,638.14	32.88	85.76	11.74

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	210.26	216.91	201.19	187.03	181.40	182.44
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	210.26	216.91	201.19	187.03	181.40	182.44
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	1.71	2.48	1.23	2.24	1.20	1.43
Total Income	211.97	219.39	202.42	189.26	182.60	183.87
Total Expenditure	178.56	183.60	173.93	162.50	155.72	158.14
PBIDT	33.41	35.79	28.49	26.76	26.88	25.73
Interest	7.56	7.48	6.48	4.94	4.91	4.64
PBDT	25.85	28.31	22.01	21.82	21.97	21.10
Depreciation	9.58	9.38	8.62	8.25	7.96	6.98
Tax	2.12	3.61	2.60	0.93	2.24	2.96
Deferred Tax	2.63	1.56	0.86	2.24	0.98	1.36
Reported Profit After Tax	11.51	13.77	9.94	10.40	10.79	9.80
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	11.51	13.77	9.94	10.40	10.79	9.80

EPS (Unit Curr.)	0.85	1.01	0.73	0.78	0.80	0.73
EPS (Adj) (Unit Curr.)	0.85	1.01	0.73	0.78	0.80	0.73
Calculated EPS (Unit Curr.)	0.85	1.01	0.73	0.78	0.80	0.73
Calculated EPS (Adj) (Unit Curr.)	0.85	1.01	0.73	0.78	0.80	0.73
Calculated EPS (Ann.) (Unit Curr.)	3.39	4.05	2.93	3.10	3.22	2.94
Calculated EPS (Adj) (Ann.) (Unit Curr.)	3.39	4.05	2.93	3.10	3.22	2.94
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	13.59	13.59	13.59	13.41	13.41	13.34
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00	1.00	1.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	15.89	16.50	14.16	14.31	14.82	14.10
PBDTM(%)	12.29	13.05	10.94	11.67	12.11	11.57
PATM(%)	5.47	6.35	4.94	5.56	5.95	5.37

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	218.78	225.01	209.54	195.28	187.45	187.46
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	218.78	225.01	209.54	195.28	187.45	187.46
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	1.78	2.42	1.25	2.38	1.24	1.41
Total Income	220.57	227.43	210.79	197.66	188.69	188.87
Total Expenditure	186.14	190.80	181.64	169.63	161.86	163.98
PBIDT	34.42	36.63	29.15	28.04	26.83	24.89
Interest	7.96	7.88	6.87	5.27	5.19	4.90
PBDT	26.47	28.75	22.28	22.77	21.65	19.99
Depreciation	10.16	9.95	9.17	8.73	8.36	7.31
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	2.12	3.61	2.60	0.93	2.24	2.96
Deferred Tax	2.63	1.65	0.76	2.40	0.78	0.95
Reported Profit After Tax	11.55	13.54	9.75	10.71	10.27	8.77
Minority Interest After NP	0.00	-0.06	-0.07	0.11	-0.18	-0.36
Net Profit after Minority Interest	11.55	13.59	9.82	10.60	10.45	9.13

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	11.55	13.59	9.82	10.60	10.45	9.13

EPS (Unit Curr.)	0.85	1.00	0.72	0.79	0.78	0.68
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	13.59	13.59	13.59	13.41	13.41	13.34

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	15.73	16.28	13.91	14.36	14.31	13.28
PBDTM(%)	12.10	12.78	10.63	11.66	11.55	10.66
PATM(%)	5.28	6.02	4.65	5.48	5.48	4.68

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	13.41	13.24	13.24	13.24	13.24	21.04
Reserves Total	393.01	348.37	308.38	300.83	280.42	210.02
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	406.42	361.61	321.62	314.07	293.66	231.06
Secured Loans	223.88	172.75	117.71	92.79	113.87	90.02
Unsecured Loans	44.32	17.64	19.31	15.32	0.31	0.88
Total Debt	268.20	190.39	137.02	108.11	114.18	90.90
Total Liabilities	674.62	552.00	458.64	422.18	407.84	321.96
APPLICATION OF FUNDS :
Gross Block	716.36	584.91	464.23	460.91	433.62	341.18
Less : Accumulated Depreciation	132.61	108.86	92.41	73.78	52.94	32.66
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	583.75	476.05	371.82	387.13	380.68	308.52
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	94.68	64.05	81.01	55.69	49.43	43.17
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	11.70	5.59	4.29	1.69	0.07	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	12.75	11.75	9.27	10.53	6.94	6.45
Sundry Debtors	84.81	69.64	52.97	76.51	78.61	55.56
Cash and Bank	48.33	27.11	28.85	15.24	12.38	12.18
Loans and Advances	12.34	14.13	14.61	14.47	14.74	13.13
Total Current Assets	158.23	122.63	105.70	116.75	112.68	87.32
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	155.78	99.69	83.72	114.07	107.35	98.04
Provisions	11.25	10.53	10.18	9.20	8.56	10.78
Total Current Liabilities	167.03	110.22	93.90	123.27	115.91	108.82
Net Current Assets	-8.80	12.41	11.80	-6.52	-3.23	-21.50
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	20.19	12.38	19.32	21.93	14.19	21.48
Deferred Tax Liability	51.55	39.36	49.15	51.38	40.01	38.95
Net Deferred Tax	-31.36	-26.98	-29.83	-29.45	-25.82	-17.47
Total Assets	649.97	531.12	439.08	408.54	401.13	312.72
Contingent Liabilities	44.36	45.74	33.75	20.50	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	15.11	16.89	11.20	9.24	3.94
Net Cash from Operating Activities	129.35	60.67	27.04	56.49	40.54
Net Cash Used In Investing Activities	-152.53	-106.10	-34.08	-21.52	-49.61
Net Cash Used In Financing Activities	29.73	43.65	12.73	-33.01	14.37
Net Inc./Dec In Cash And Cash Equivalents	6.55	-1.77	5.69	1.96	5.30
Cash And Cash Equivalents At End Of The Year	21.67	15.11	16.89	11.20	9.24

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

68.03%

FII Shareholding

0.10%

DII Shareholding

9.78%

Public Shareholding

22.08%

**Promoter pledged shareholding 68.03%

About Artemis Medicare Services Ltd

Artemis Medicare Services Ltd is in the Healthcare sector, having a market capitalization of Rs. 2519.94 crores. It has reported a sales of Rs. 210.26 crores and a net profit of Rs. 11.51 crores for the quarter ended December 2018. The company management includes Onkar S Kanwar, Deepa Gopalan Wadhwa,Sunil Tandon,Shalini Kanwar Chand,Onkar S Kanwar,Neeraj Kanwar,S Narayan,Nirmal Kumar Ganguly,Sanjaya Baru,Sanjib Sen,Devlina Chakravarty,Poonam Makkar. (Artemis Medicare Services Ltd) among others.

Chairman

Onkar S Kanwar

Registered office

Plot No 14 Sector 20,Dwarka,New Delhi,Delhi,110075

FAX :

Background

Incorporation Year2004

Face Value₹1

Market Lot1

How to buy Artemis Medicare shares on nse?

To buy Artemis Medicare shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Artemis Medicare share price today?

The Artemis Medicare shares price on nse is Rs.183.2 today.

What is the market cap of Artemis Medicare shares on BSE ?

The company has a market capitalization of Rs.2519.94Cr

What is the PE & PB ratio of Artemis Medicare shares ?

PE is 55.27 and PB is 7.05

What is the 52 Week High and Low of Artemis Medicare shares?

Artemis Medicare stock price high: Rs.195.55 Artemis Medicare stock price low: Rs.73.75